Clinical Trial Update: Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia [Phase 2]

View source ↗

Summary

Phase 2 extension study of GI198745 for benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• GI198745

Snippet

Sponsor: GlaxoSmithKline | Conditions: Benign Prostatic Hyperplasia, Prostatic Hyperplasia | Phase 2 | Status: COMPLETED